BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19 ; volume:13 ; number:1 ; day:18 ; month:8 ; year:2022 ; pages:1-10 ; date:12.2022
Nature Communications ; 13, Heft 1 (18.8.2022), 1-10, 12.2022
- Creator
-
Behrens, Georg Martin Norbert
Barros-Martins, Joana
Cossmann, Anne
Ramos, Gema Morillas
Stankov, Metodi V.
Odak, Ivan
Jablonka, Alexandra
Hetzel, Laura
Köhler, Miriam
Patzer, Gwendolyn
Binz, Christoph
Ritter, Christiane
Friedrichsen, Michaela
Schultze-Florey, Christian
Ravens, Inga
Willenzon, Stefanie
Bubke, Anja
Ristenpart, Jasmin
Janssen, Anika
Ssebyatika, George
Krähling, Verena
Bernhardt, Günter
Hoffmann, Markus
Pöhlmann, Stefan
Krey, Thomas
Bošnjak, Berislav
Hammerschmidt, Swantje I.
Förster, Reinhold
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32527-2
- URN
-
urn:nbn:de:101:1-2022110512354447223417
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Behrens, Georg Martin Norbert
- Barros-Martins, Joana
- Cossmann, Anne
- Ramos, Gema Morillas
- Stankov, Metodi V.
- Odak, Ivan
- Jablonka, Alexandra
- Hetzel, Laura
- Köhler, Miriam
- Patzer, Gwendolyn
- Binz, Christoph
- Ritter, Christiane
- Friedrichsen, Michaela
- Schultze-Florey, Christian
- Ravens, Inga
- Willenzon, Stefanie
- Bubke, Anja
- Ristenpart, Jasmin
- Janssen, Anika
- Ssebyatika, George
- Krähling, Verena
- Bernhardt, Günter
- Hoffmann, Markus
- Pöhlmann, Stefan
- Krey, Thomas
- Bošnjak, Berislav
- Hammerschmidt, Swantje I.
- Förster, Reinhold
- SpringerLink (Online service)
Other Objects (12)
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
Myopericarditis following both BNT162b2 and NVX-CoV2373
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
Myopericarditis following both BNT162b2 and NVX-CoV2373
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Duration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
Myopericarditis following both BNT162b2 and NVX-CoV2373
Differential immunogenicity of BNT162b2 or ChAdOx1 vaccines after extended-interval homologous dual vaccination in older people
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Heterologous prime-boost immunization with ChAdOx1-S and BNT162b2: reactogenicity and immunogenicity in a prospective cohort study